发明授权
US08476239B2 Stable protein formulations 有权
稳定的蛋白质配方

Stable protein formulations
摘要:
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
公开/授权文献
信息查询
0/0